Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clotrimazole + lactulose is a combination drug under investigation for the treatment of candidal vaginitis and vulvovaginitis. Clotrimazole is an azole antifungal that inhibits the synthesis of ergosterol, a key component of fungal cell membranes, leading to increased membrane permeability and cell death. Lactulose is a synthetic sugar primarily used as an osmotic laxative and for reducing blood ammonia levels in hepatic encephalopathy; in this combination, it may serve as an excipient or to enhance local effects. The combination has been studied in vaginal suppository form to compare its efficacy and safety against clotrimazole monotherapy for vaginal yeast infections[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clotrimazole + lactulose.